Lynette M. Moore, et.al., IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas., Proceedings of the National Academy of Sciences of the United States of America, 2009, 106

http://rdf.ncbi.nlm.nih.gov/pubmed/19805356

Lynette M. Moore, et.al., IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas., Proceedings of the National Academy of Sciences of the United States of America, 2009, 106

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased oligodendroglioma incidence_Cdkn2a<tm1Rdp>/Cdkn2a<tm1Rdp>,Tg(NES-TVA)J12Ech/0
  http://metadb.riken.jp/0010312I129SvC57BL6FVBNSJLCdkn2atm1RdpCdkn2atm1RdpTgNESTVAJ12Ech0TgNESTVAJ12EchCdkn2atm1Rdp
• premature death_Cdkn2a<tm1Rdp>/Cdkn2a<tm1Rdp>,Tg(NES-TVA)J12Ech/0
  http://metadb.riken.jp/0002083I129SvC57BL6FVBNSJLCdkn2atm1RdpCdkn2atm1RdpTgNESTVAJ12Ech0TgNESTVAJ12EchCdkn2atm1Rdp